Open AccessInhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones
Author(s) -
Arthur S. Dobek,
Daniel L. Klayman,
Edward T. Dickson,
John P. Scovill,
Edmund C. Tramont
Publication year - 1980
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.18.1.27
Subject(s) - microbiology and biotechnology , enterobacter , staphylococcus aureus , proteus , enterococcus , klebsiella , enterococcus faecalis , citrobacter , antibacterial activity , escherichia coli , minimum inhibitory concentration , biology , enterobacteriaceae , pseudomonas , neisseria gonorrhoeae , bacilli , shigella , antibacterial agent , pseudomonas aeruginosa , shigella flexneri , bacteria , antibiotics , biochemistry , genetics , gene
Antibacterial activity of 65 2-acetylpyridine thiosemicarbazones and related compounds was determined by using clinical isolates of nine bacterial genera. Minimal inhibitory concentrations (MICs) of 0.002 to 0.062 micrograms/ml were obtained with 23% of the compounds for Neisseria gonorrhoeae and 0.016 to 0.062 micrograms/ml with 17% of the compounds for N. meningitidis. Staphylococcus aureus was inhibited in the MIC range of 0.125 to 0.5 micrograms/ml by 18% of the thiosemicarbazones, whereas 26% inhibited group D enterococcus with an MIC of 0.25 to 2.0 micrograms/ml. Poor antibacterial activity was shown toward the gram-negative bacilli, i.e., Pseudomonas, Klebsiella-Enterobacter, Shigella, Escherichia coli, and Proteus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom